Swipe om te navigeren naar een ander artikel
Quality of life is impaired in some people with IBS, but the level of symptoms that may drive this impairment is unclear.
We aimed to identify whether current frequency and severity cut-offs for IBS-type symptoms are associated with a clinically meaningful impairment of quality of life in the community.
People who met modified Rome III criteria for IBS (n = 201) and controls (n = 1,904) were assessed. Frequency of IBS symptoms was grouped a priori into ‘less frequent’ (not at all and sometimes) and ‘more’ frequent (often, very often and almost always). Severity of abdominal pain was grouped into ‘mild’ (very mild and mild) and severe (moderate, severe and very severe). Mental and physical functioning was measured using the valid SF-12, with ‘normal’ functioning (defined as a score of >43 and >48) and ‘impaired’ functioning (defined as a score of ≤43 and ≤48), respectively. Psychological variables were assessed via valid self-report.
Having ‘more’ versus ‘less’ severe abdominal pain (OR = 9.41; 95% CI 1.17–75.43, P = 0.03) and ‘more’ versus ‘less’ frequent diarrhoea (OR = 2.19; 95% CI 1.13–4.26, P = 0.02) along with increasing age (OR = 1.03; 95% CI 1.01–1.05, P = 0.003) were significant independent predictors of having impairment in physical functioning. In terms of psychological factors, having higher levels of depression (OR = 1.61; 95% CI 1.36–1.91) and somatic distress (OR = 1.17; 95% CI 1.09–1.27) were independently associated with mental and physical impairment, respectively.
The current frequency and severity threshold cut-offs for IBS symptoms in the Rome III criteria are associated with a clinically meaningful impairment of quality of life in community subjects with IBS.
Log in om toegang te krijgen
Met onderstaand(e) abonnement(en) heeft u direct toegang:
Drossman, D. A., Richter, J. E., Talley, N. J., Thompson, G. W., Corazziari, E., & Whitehead, W. E. (Eds.). (1994). The functional gastrointestinal disorders. Diagnosis, pathophysiology and treatment—A multinational consensus. Boston: Little, Brown and Co.
Owens, D. M., Nelson, D. K., & Talley, N. J. (1995). The irritable bowel syndrome: Long-term prognosis and the physician–patient interaction. Annals of Internal Medicine, 122, 107–112. PubMed
Guyatt, G. H., Veldhuyzen Van Zanten, S. J. O., Feeny, D. H., & Patrick, D. L. (1989). Measuring quality of life in clinical trials: A taxonomy and review. Canadian Medical Association Journal, 140, 1441–1448. PubMed
Creed, F., Ratcliffe, J., Fernandez, L., Tomenson, B., Palmer, S., Rigby, C., et al. (2001). Health-related quality of life and health care costs in severe, refractory irritable bowel syndrome. Annals of Internal Medicine, 134, 860–868. PubMed
Li, F. X., Patten, S. B., Hilsden, R. J., & Sutherland, L. R. (2003). Irritable bowel syndrome and health-related quality of life. A population-based study in Calgary, Alberta. Canadian Journal of Gastroenterology, 17, 259–263. PubMed
O’Keefe, E. A., Talley, N. J., Zinsmeister, A. R., & Jacobsen, S. J. (1995). Bowel disorders impair functional status and quality of life in the elderly: A population-based study. Journal of Gerontology Series A-Biological Sciences & Medical Sciences, 50, 184–189. CrossRef
Hahn, B. A., Kirchdoerfer, L. J., Fullerton, S., & Mayer, E. (1997). Patient perceived severity of irritable bowel syndrome in relation to symptoms, health resource utilization and quality of life. Alimentary Pharmacology & Therapeutics, 11, 553–559.
Halder, S. L., Locke, G. R., I. I. I., Talley, N. J., Fett, S. L., Zinsmeister, A. R., & Melton, L. J., I. I. I. (2004). Impact of functional gastrointestinal disorders on health-related quality of life: A population-based case-control study. Alimentary Pharmacology & Therapeutics, 19, 233–242. CrossRef
Wilson, A., Longstreth, G. F., Knight, K., Wong, J., Wade, S., Chiou, C. F., et al. (2004). Quality of life in managed care patients with irritable bowel syndrome. Managed Care Interface, 17, 24–28. PubMed
Australian Bureau of Statistics. (1991). Census of population and housing, basic community profile: Area 6350 Penrith, ABS catalogue no. 2722. Sydney, Australia: Australian Bureau of Statistics.
Koloski, N. A., Talley, N. J., Boyce, P. M., & Morris-Yates, A. D. (2001). The effect of questionnaire length and lottery ticket incentive on the response rate in mail surveys. Psychology & Health, 16, 67–75. CrossRef
Eysenck, H. J., & Eysenck, S. B. G. (1975). Manual of the Eysenck personality questionnaire. London: Hodder & Stoughton.
Bedford, A., Foulds, G. A., & Sheffield, B. F. (1976). A new personal disturbance scale (DSSI/sAD). British Journal of Social Clinical Psychology, 15, 387–394. CrossRef
Hadzi-Pavlovic, D., Hickie, I., Ricci, C. (1997). The Sphere. Somatic and psychological health report. Development and initial evaluation. Technical report TR- 97- 002. School of Psychiatry, University of NSW and Academic Department of Psychiatry at St. George Hospital.
Ware, J. E., Kosinski, M., Keller, S. D. (1994). SF- 36 physical and mental health summary scales: A user’s manual. Boston, MA: The Health Institute, New England Medical Center.
Ware, J. E., Kosinski, M., Bjorner, J. B., Turner-Bowker, D. M., & Maruish, M. E. (2007). User’s manual for the SF-36 health survey (Version 2) (2nd ed.). Lincoln, RI: Qualitymetric Incorporated.
Rome Foundation. (2006). Guidelines—Rome III diagnostic criteria for functional gastrointestinal disorders. Journal of Gastrointestinal & Liver Diseases, 15, 307–312.
Jones, M. P., Wessinger, S., & Crowell, M. D. (2006). Coping strategies and interpersonal support in patients with irritable bowel syndrome and inflammatory bowel disease. Clinical Gastroenterology & Hepatology, 4, 474–481. CrossRef
What level of IBS symptoms drives impairment in health-related quality of life in community subjects with irritable bowel syndrome?
Are current IBS symptom thresholds clinically meaningful?
Natasha A. Koloski
Philip M. Boyce
Michael P. Jones
Nicholas J. Talley
- Springer Netherlands